Found 162 matching trials
Induced Tolerogenic Dendritic Cells as Modulators of Allergic Asthma PHASE1 Despite advances in medications, allergic diseases, including allergic asth...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
177^Lu-PSMA-617 in Combination With Sipuleucel-T for the Treatment of Metastatic Castration-Resistant Prostate Cancer PHASE1 This phase I trial compares the effect of lutetium Lu 177 (177\^Lu)-prostat...
Show More Location
City of Hope Medical Center
Learn More & Join Trial
Dendritic Cell-based Immunotherapy in Treatment Gastric Cancer PHASE2 Study objectives are to investigate the efficacy and safety of activated au...
Show More Location
Lanzhou University Second Hospital
Learn More & Join Trial
Type I-Polarized Autologous Dendritic Cell Vaccine With Tumor Blood Vessel Antigen-Derived Peptides in Metastatic Breast Cancer Patients PHASE1 This pilot clinical trial studies the safety of a dendritic cell vaccine wh...
Show More Location
University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center
Learn More & Join Trial
Study to Determine the Effect of an Anti-IgE Agent on Inflammatory Cells in the Skin of Atopic Dermatitis Patients PHASE4 Elevated levels of immunoglobuline E in blood are said to promote the occur...
Show More Location
Division of Immunology, Allergy and Infectious Diseases, Department of Dermatology, Medical University of Vienna, Austria.
Learn More & Join Trial
Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer PHASE1 This phase I/II trial tests the safety, side effects, best dose, and effect...
Show More Location
Mayo Clinic in Arizona
Learn More & Join Trial
Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer PHASE2 RATIONALE: Vaccines made from a person's white blood cells and allogeneic t...
Show More Location
Markey Cancer Center at University of Kentucky Chandler Medical Center
Learn More & Join Trial
A Phase I/II Clinical Trial on the Per-operative Intratumoral Administration of Myeloid Dendritic Cells Plus Ipilimumab and Nivolumab, Followed by Repeated Intracavitary Plus Intravenous Administration of Nivolumab in Patients With Recurrent Glioblastoma. PHASE1 Phase I/II clinical trial on the per-operative intra-tumoral administration...
Show More Status
Active Not Recruiting
Location
Universitair Ziekenhuis Brussel
Learn More & Join Trial
CD8 Reactivity to Microorganisms in Blood and Breast Milk N/A Background:
When a person is exposed to something that causes an infection...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab PHASE2 The purpose of the study is to find out if an investigational drug called D...
Show More Location
Moffitt Cancer Center
Learn More & Join Trial